Schwannomatosis

Revision as of 15:54, 20 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Schwannomatosis

Articles

Most recent articles on Schwannomatosis

Most cited articles on Schwannomatosis

Review articles on Schwannomatosis

Articles on Schwannomatosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Schwannomatosis

Images of Schwannomatosis

Photos of Schwannomatosis

Podcasts & MP3s on Schwannomatosis

Videos on Schwannomatosis

Evidence Based Medicine

Cochrane Collaboration on Schwannomatosis

Bandolier on Schwannomatosis

TRIP on Schwannomatosis

Clinical Trials

Ongoing Trials on Schwannomatosis at Clinical Trials.gov

Trial results on Schwannomatosis

Clinical Trials on Schwannomatosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Schwannomatosis

NICE Guidance on Schwannomatosis

NHS PRODIGY Guidance

FDA on Schwannomatosis

CDC on Schwannomatosis

Books

Books on Schwannomatosis

News

Schwannomatosis in the news

Be alerted to news on Schwannomatosis

News trends on Schwannomatosis

Commentary

Blogs on Schwannomatosis

Definitions

Definitions of Schwannomatosis

Patient Resources / Community

Patient resources on Schwannomatosis

Discussion groups on Schwannomatosis

Patient Handouts on Schwannomatosis

Directions to Hospitals Treating Schwannomatosis

Risk calculators and risk factors for Schwannomatosis

Healthcare Provider Resources

Symptoms of Schwannomatosis

Causes & Risk Factors for Schwannomatosis

Diagnostic studies for Schwannomatosis

Treatment of Schwannomatosis

Continuing Medical Education (CME)

CME Programs on Schwannomatosis

International

Schwannomatosis en Espanol

Schwannomatosis en Francais

Business

Schwannomatosis in the Marketplace

Patents on Schwannomatosis

Experimental / Informatics

List of terms related to Schwannomatosis


Overview

Schwannomatosis is one form of a genetic disorder called Neurofibromatosis (NF) that has only recently been recognized. It is a rare disorder, affecting only around 1:40,000 individuals.

Symptoms

  • Schwannomas occur instead of Neurofibromas.
  • Multiple Schwannomas occur.
  • The Schwannomas develop on cranial, spinal and peripheral nerves.
  • Chronic pain, and sometimes numbness, tingling and weakness.
  • About 1/3 of patients have segmental Schwannomatosis, which means that the Schwannomas are limited to a single part of the body, such as an arm, a leg or the spine.
  • There are several cases where people with Schwannomatosis have developed a vestibular Schwannoma (acoustic neuroma).
  • Patients with Schwannomatosis do not have learning disabilities related to the disease.
  • Symptoms are generally brought on by hormonal changes such as puberty and pregnancy.

Cause

  • Like the NF1 and NF2 genes, the candidate Schwannomatosis gene, named INI1, is a tumor suppressor that regulates cell cycle, growth and differentiation. INI1 is also known as SMARCB1, hSNF5, or BAF47, and lies on human Chromosome 22. INI1 is also mutated in other tumors including malignant brain & kidney tumors in infants.
  • Schwannomatosis is known to be a genetic disorder, however it can skip generations.

Treatment

  • If feasible, the Schwannomas can be surgically removed. Any tumor-associated pain usually subsides after tumor removal. Damaged nerves and scar tissue can be a result of surgery and pain can be an ongoing problem.
  • Sometimes, a tumor will reappear at the same site after surgery.
  • If surgery is unfeasible, then pain management will have to be used. Schwannomatosis can sometimes cause severe, untreatable pain over time.
  • Other than surgery and/or pain management, there are no other medical treatments available. There are no drugs available to treat Schwannomatosis.
  • Gamma knife surgery can be performed on head tumors to help slow growth of a tumor, although there is no guarantee that it will work.
  • Recently, many advances are being made in the treatment of schwannomas. Of interest is CyberKnife, manufactured by Accuray. Success rates, although limited in data, appear to be in the low to mid ninety percent range.

Template:WikiDoc Sources